LIV-GAMMA SN Inj. ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
63特発性血小板減少性紫斑病2

63. 特発性血小板減少性紫斑病


臨床試験数 : 391 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05566990
(ClinicalTrials.gov)
July 19, 201930/9/2022A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)A Multicenter, Open-Label, Phase III Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)Immune ThrombocytopeniaBiological: LIV-GAMMA SN Inj.10%SK Plasma Co., Ltd.NULLCompleted19 YearsN/AAll34Phase 3Korea, Republic of
2NCT03164915
(ClinicalTrials.gov)
October 24, 201622/5/2017A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)A Multicenter, Open-Label, Phase III Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)Immune ThrombocytopeniaBiological: LIV-GAMMA SN Inj.SK Plasma Co., Ltd.NULLCompleted19 YearsN/AAll37Phase 3Korea, Republic of